REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

28/10/2020 17:50

RNS Number : 5383D
  
GlaxoSmithKline PLC
  
28 October 2020
  
 

GlaxoSmithKline plc (the 'Company')
Transaction notification
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Sir Jonathan Symonds




b)


Position/status


Non-Executive Chairman
 




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
 




b)


Nature of the transaction


Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


£13.50


3,240.741


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr Charles Bancroft 




b)


Position/status


Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


$35.29


866.616


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr Vindi Banga




b)


Position/status


Senior Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
 




b)


Nature of the transaction


Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


£13.50


671.296


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Dr Vivienne Cox




b)


Position/status


Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
 




b)


Nature of the transaction


Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


£13.50


625.000


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Ms Lynn Elsenhans




b)


Position/status


Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


$35.29


615.753


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Dr Laurie Glimcher




b)


Position/status


Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 
 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


$35.29


1,140.284


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Dr Jesse Goodman




b)


Position/status


Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


$35.29


376.294


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Ms Judy Lewent




b)


Position/status


Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


$35.29


399.099


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr Urs Rohner




b)


Position/status


Independent Non-Executive Director




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
 




b)


Nature of the transaction


Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2020 to 30 September 2020. 
 




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


£13.50


625.000


 




 


 


 


 




d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2020-10-28




f)


Place of the transaction
 


N/A




 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHDVLFLBBLZFBE